🔬 Korean Biotech Company K-Medichem Expands Global Market
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansionCHUNCHEON, South Korea, Sept. 8, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based,
Key points
- PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansionCHUNCHEON, South Korea, Sept.
- 8, 2026 /PRNewswire/ -- K-Medichem Co.
- (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS.
- With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based,
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #science
- #korean
- #biotech